Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Tradeweb Markets Inc. TW | Capital Research Global Investors | 7,470,318 7.100% | 7,470,318 (New Position) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Thor Industries, Inc. THO | Capital Research Global Investors | 4,863,269 8.700% | -1,918,659 (-28.29%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Stifel Financial Corp. SF | Capital Research Global Investors | 6,080,494 5.800% | 106,288 (+1.78%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Stanley Black & Decker, Inc. SWK | Capital Research Global Investors | 5,689,119 3.500% | -4,763,654 (-45.57%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Revvity, Inc. RVTY | Capital Research Global Investors | 13,082,180 10.400% | 908,188 (+7.46%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | PAR Technology Corporation PAR | Capital Research Global Investors | 3,092,461 11.500% | 443,610 (+16.75%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Old Dominion Freight Line, Inc. ODFL | Capital Research Global Investors | 13,022,490 5.700% | -3,951,682 (-23.28%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Montrose Environmental Group, Inc. MEG | Capital Research Global Investors | 2,179,882 7.400% | 2,179,882 (New Position) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Mattel, Inc. MAT | Capital Research Global Investors | 18,094,976 5.200% | 3,404 (+0.02%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 8,219,133 9.700% | -18,148 (-0.22%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Hasbro, Inc. HAS | Capital Research Global Investors | 15,412,364 11.200% | 1,959,914 (+14.57%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,049,133 4.000% | -726,503 (-26.17%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Granite Construction Incorporated GVA | Capital Research Global Investors | 923,892 2.000% | -2,441,608 (-72.55%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Golden Entertainment, Inc. GDEN | Capital Research Global Investors | 1,625,000 5.600% | 1,625,000 (New Position) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 107,156,981 8.500% | -14,515,418 (-11.93%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Freshpet, Inc. FRPT | Capital Research Global Investors | 3,164,445 7.300% | 3,164,445 (New Position) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | Edison International EIX | Capital Research Global Investors | 21,567,094 5.700% | 21,567,094 (New Position) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | CSX Corporation CSX | Capital Research Global Investors | 111,241,858 5.000% | -45,079,490 (-28.84%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Amgen Inc. AMGN | Capital Research Global Investors | 22,157,906 3.900% | -9,604,421 (-30.24%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital Research Global Investors | 0 0.000% | -12,640,338 (Position Closed) | Filing History |